Live
← Latest weekly briefing
Weekly intelligence · 2026-W46

The Nordic week,
distilled.

9 Nov–15 Nov 2026Week to dateUpdated Nov 15, 2026
Executive summary

This week, Switchpoint Bio emerged from stealth mode, securing €4.75 million in funding to develop its innovative blood-based epigenomic platform aimed at transforming drug response analysis. This funding positions the startup to significantly impact disease treatment and drug development processes. Additionally, several startups raised funds to enhance their offerings, indicating a vibrant funding landscape in the TechBio and accounting sectors across Europe.

The week at a glance

Three things to know

Essential reading

The stories that mattered

Selected for consequence, evidence and relevance across the Nordic startup ecosystem.

What to watch next

The next signals to follow

Stay tuned for updates from Slush 2026, where numerous startups will showcase their innovations.

Previous editions

From the weekly archive

Show 5 more editions